Repligen Corp. (RGEN)
188.84
+4.15
(+2.25%)
USD |
NASDAQ |
Oct 29, 13:19
Repligen Market Cap : 10.66B for Oct. 29, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 28, 2026 | 10.42B |
| October 27, 2026 | 9.920B |
| October 26, 2026 | 10.17B |
| October 23, 2026 | 9.984B |
| October 22, 2026 | 10.08B |
| October 21, 2026 | 10.16B |
| October 20, 2026 | 10.09B |
| October 19, 2026 | 9.955B |
| October 16, 2026 | 9.898B |
| October 15, 2026 | 10.39B |
| October 14, 2026 | 10.06B |
| October 13, 2026 | 9.898B |
| October 12, 2026 | 9.734B |
| October 09, 2026 | 9.812B |
| October 08, 2026 | 9.245B |
| October 07, 2026 | 9.436B |
| October 06, 2026 | 9.867B |
| October 05, 2026 | 10.69B |
| October 02, 2026 | 10.25B |
| October 01, 2026 | 10.00B |
| September 30, 2026 | 10.85B |
| September 29, 2026 | 10.98B |
| September 28, 2026 | 10.95B |
| September 25, 2026 | 10.70B |
| September 24, 2026 | 10.76B |
| Date | Value |
|---|---|
| September 23, 2026 | 10.41B |
| September 22, 2026 | 10.54B |
| September 21, 2026 | 10.20B |
| September 18, 2026 | 9.981B |
| September 17, 2026 | 10.05B |
| September 16, 2026 | 9.757B |
| September 15, 2026 | 9.860B |
| September 14, 2026 | 9.480B |
| September 11, 2026 | 9.321B |
| September 10, 2026 | 9.292B |
| September 09, 2026 | 9.313B |
| September 08, 2026 | 9.510B |
| September 04, 2026 | 9.457B |
| September 03, 2026 | 9.571B |
| September 02, 2026 | 9.759B |
| September 01, 2026 | 9.594B |
| August 31, 2026 | 10.21B |
| August 28, 2026 | 9.946B |
| August 27, 2026 | 10.27B |
| August 26, 2026 | 10.17B |
| August 25, 2026 | 10.25B |
| August 24, 2026 | 10.25B |
| August 21, 2026 | 10.22B |
| August 20, 2026 | 10.17B |
| August 19, 2026 | 9.951B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Anika Therapeutics, Inc. | 287.20M |
| Precigen, Inc. | 2.442B |
| Liquidia Corp. | 3.991B |
| Harmony Biosciences Holdings, Inc. | 2.250B |
| Agilent Technologies, Inc. | 51.22B |
Market Cap Related Metrics
| PS Ratio | 13.27 |
| Price to Book Value | 5.118 |
| Price to Free Cash Flow | 101.60 |
| Price | 188.84 |
| Earnings Yield | -0.11% |
| Operating PE Ratio | 154.75 |
| Normalized PE Ratio | 449.73 |